• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cibus Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/23/25 4:35:25 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email
    cbus-20250522
    0001705843FALSE00017058432025-05-222025-05-22

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ______________________
    FORM 8-K
    ______________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report: (Date of earliest event reported): May 22, 2025
    ______________________
    Cibus, Inc.
    (Exact name of registrant as specified in its charter)
    ______________________
    Delaware001-3816127-1967997
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    6455 Nancy Ridge Drive
    San Diego, CA
    92121
    (Address of principal executive offices)(Zip Code)
    (858) 450-0008
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former name or former address, if changed since last report)
    ______________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of exchange
    on which registered
    Class A Common Stock, $0.0001 par value per shareCBUSThe NASDAQ Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 5.07.     Submission of Matters to a Vote of Security Holders.

    On May 22, 2025, Cibus, Inc., (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Of the 32,850,026 shares of Class A Common Stock, $0.0001 par value per share (“Class A Common Stock”) (including 211,615 restricted shares of Class A Common Stock that remain subject to vesting) and 1,712,373 shares of Class B Common Stock, par value $0.0001 per share, outstanding and entitled to vote at the Annual Meeting on the March 24, 2025 record date, 22,447,245 shares, or approximately 64.94%, were present at the Annual Meeting either by attendance via online webcast or represented by proxy, constituting a quorum.

    The following describes the matters considered by the Company’s stockholders at the Annual Meeting, as well as the results of the votes cast at the meeting:

    1. To elect seven directors to our Board of Directors, each to serve until the next annual meeting of stockholders and until his successor has been elected and qualified, or until his earlier death, resignation, or removal.

    Nominee
    For
    Against
    Abstain
    Broker Non-Vote
    Rory Riggs
    13,229,709361,47752,7768,803,283
    Peter Beetham
    13,494,157125,90223,9038,803,283
    Mark Finn
    12,679,147951,73913,0768,803,283
    Jean-Pierre Lehmann
    12,737,659879,97226,3318,803,283
    August Moretti13,524,117103,53516,3108,803,283
    Gerhard Prante
    13,347,574279,60816,7808,803,283
    Keith Walker
    12,613,298962,05968,6058,803,283

    2. To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers.

    For
    Against
    Abstain
    Broker Non-Vote
    13,207,604192,690243,6688,803,283

    3. To ratify the appointment by the Audit Committee of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 31, 2025.

    For
    Against
    Abstain
    Broker Non-Vote
    20,519,5881,899,34828,309—

    4. To approve the adoption of the Cibus, Inc. 2025 Employee Stock Purchase Plan.

    For
    Against
    Abstain
    Broker Non-Vote
    12,746,067691,145206,7508,803,283


    5. To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 9,040,000 shares of Class A common stock issuable upon the exercise of outstanding common warrants issued pursuant to those certain Securities Purchase Agreements, each dated January 21, 2025, by and among the Company and the purchasers party thereto.

    For
    Against
    Abstain
    Broker Non-Vote
    13,205,793420,92917,2408,803,283




    6. To approve, in accordance with Nasdaq Listing Rule 5635(c), the repricing of certain existing warrants of the Company held by Rory Riggs.

    For
    Against
    Abstain
    Broker Non-Vote
    13,143,866468,37031,7268,803,283

    7. To approve, in accordance with Nasdaq Listing Rule 5635(b), the issuance of shares of Class A common stock upon the potential future exercise of certain outstanding warrants held by Rory Riggs, that would be deemed to be a “change of control” of the Company within the meaning of Nasdaq Listing Rule 5635(b).

    For
    Against
    Abstain
    Broker Non-Vote
    12,806,271793,33044,3618,803,283

    As a result, at the Annual Meeting, Rory Riggs, Peter Beetham, Mark Finn, Jean-Pierre Lehmann, August Moretti, Gerhard Prante and Keith Walker were elected as directors of the Company, each to serve a one-year term, the compensation of Company’s named executive officers was approved (on an advisory basis), and the appointment of BDO USA, P.C. was ratified, the Cibus, Inc. 2025 Employee Stock Purchase Plan was approved, the issuance of up to 9,040,000 shares of Class A common stock issuable upon the exercise of certain outstanding common warrants was approved, the repricing of certain existing warrants of the Company held by Rory Riggs was approved, and the issuance of shares of Class A common stock upon the potential future exercise of certain outstanding warrants held by Rory Riggs, that would be deemed to be a “change of control” of the Company within the meaning of Nasdaq Listing Rule 5635(b), was approved.








    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Dated: May 23, 2025
    CIBUS, INC.
    By:/s/ Peter Beetham
    Name:Peter Beetham
    Title:Interim Chief Executive Officer

    Get the next $CBUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock

    SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering (the "Offering") of 6,976,744 shares of its Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") at a purchase price of $2.15 per share of Class A Common Stock. The Company has also granted the underwriter a 30-day option to purchase up to an additional 1,046,511 shares of Class A Common Stock to cover over-allotments, if any. All shares of Class A Common Stock to be sold in the Offering are to be sold by th

    3/26/26 6:55:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

    SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share ("Class A Common Stock") and, in lieu of common stock to certain investors that so elect, pre-funded warrants to purchase additional shares of its Class A Common Stock in an underwritten public offering (the "Offering"). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Off

    3/25/26 4:01:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports Fourth Quarter Financial Results and Provides Business Update

    SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended December 31, 2025, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET. Management Commentary Peter Beetham, Interim Chief Executive Officer of Cibus, commented, "2025 was a landmark year that validated our technology leadership and strategic vision. Our seven Rice partner customers continue to drive our near-term 2027 and 2028 commercial launch targets in our USA and LATAM geographic marke

    3/17/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    SEC Filings

    View All

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    3/27/26 8:45:14 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 424B5 filed by Cibus Inc.

    424B5 - Cibus, Inc. (0001705843) (Filer)

    3/26/26 5:24:44 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 424B5 filed by Cibus Inc.

    424B5 - Cibus, Inc. (0001705843) (Filer)

    3/25/26 4:12:27 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sauer Noel

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 12:03:47 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Stokes Jason

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 12:00:59 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Broos Carlo

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 11:57:01 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Craig Wichner to Board of Directors

    SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Craig Wichner to its Board of Directors. Mr. Wichner will also serve as a member of the Board's current Strategy Committee. "Craig brings an exceptional combination of financial acumen, strategic discipline, and industry insight to the Cibus Board," said Mark Finn, Chairman of the Board of Cibus. "As Cibus prepares for anticipated commercial scaling of our trait platform, Craig's expertise in sustainable growth and capital strategy in agriculture will be instrumental in strengthening our

    11/11/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call

    SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report fourth quarter 2025 financial results on Tuesday, March 17, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Fourth Quarter 2025 Results Conference Call Event Date: Tuesday, March 17, 2026Time: 4:30 p.m. ETParticipant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)The conference ID "CIBUS" or 24287 will be required for entryEv

    3/3/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice growers to new solutions to scale crop productivity through advanced gene editing Successfully completed pre-commercial pilot runs for certain biofragrance products; commercial expansion targeted for 2026 Positive field trial results for HT2 in Canola in North America; HT2 and Sclerotinia resistance

    11/13/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025         Time: 4:30 p.m. ET         Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will

    10/30/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials